Today's biggest pre-market stock movers: ARNA, FHTX, PTPI and more
Today's biggest pre-market stock movers: ARNA, FHTX, PTPI and more
Gainers
贏家
$Arena Pharmaceuticals(ARNA.US)$ stock is rocketing more than 91% on news that $Pfizer(PFE.US)$ is buying the company in a $6.7 billion deal.
$Foghorn Therapeutics(FHTX.US)$ shares are soaring over 38% following news of a cancer team up with $Eli Lilly and Co(LLY.US)$.
$Petros Pharmaceuticals(PTPI.US)$ stock is surging close to 16%, which continues a rally from Friday.
$Boxlight(BOXL.US)$ shares are rising more than 4% after H.C. Wainwright analyst Scott Buck initiated coverage of the company.
$bluebird bio(BLUE.US)$ stock is gaining over 8% thanks to positive clinical trial data.
$Midatech Pharma(MTP.US)$ shares are sitting more than 16% higher after announcing an Investigational New Drug application for MTX110.
$Aptevo Therapeutics(APVO.US)$ stock is increasing over 14% despite a lack of news this morning.
$MediciNova(MNOV.US)$ shares are getting a more than 13% boost after getting notice of allowance for a new patent covering MN-166.
$Clear Channel Outdoor(CCO.US)$ stock is jumping over 13% after announcing a review of strategic alternatives for its European business as well as updated Q4 guidance.
$American Virtual(AVCT.US)$ shares are up more than 12% as they continue to rally from partnership news last week.
$Arena PharmPharmticals(ARNA.US)$消息傳出後，股價飆升超過91%$輝瑞(PFE.US)$正在以67億美元的價格收購該公司。
$福格霍恩治療公司(FHTX.US)$在有消息稱一個癌症團隊與$禮來(LLY美國)$。
$Petros PharmPharmticals(PTPI.US)$股價飆升近16%，延續了上週五以來的漲勢。
$Boxlight(BOXL.US)$在H.C.Wainwright分析師斯科特·巴克發起對該公司的報道後，該公司股價上漲超過4%。
$Bluebird Bio(BLUE.US)$由於積極的臨床試驗數據，股票上漲了8%以上。
$Midatech Pharma(MTP.US)$在宣佈MTX110的研究新藥申請後，股價上漲了16%以上。
$Aptevo Treateutics(APVO.US)$儘管今早沒有消息，但股價仍上漲了14%以上。
$MediciNova(MNOV.US)$在收到一項涵蓋MN-166的新專利的許可通知後，股價上漲了13%以上。
$Clear Channel戶外頻道(CCO.US)$在宣佈對其歐洲業務的戰略選擇進行審查以及更新第四季度指引後，該公司股價躍升逾13%。
$American Virtual(AVCT.US)$上週，該公司股價因合作消息而繼續上漲，漲幅超過12%。
Losers
失敗者
$Blonder Tongue Laboratories(BDR.US)$ stock is diving 25% after being sent a delisting notice last week.
$Avenue Therapeutics(ATXI.US)$ shares are taking an over 21% beating after pricing an underwritten $2 million stock offering.
$Ishares Us Etf Trust Commodities Select Strategy(COMT.US)$ stock is slipping more than 15% in pre-market trading today.
$TherapeuticsMD(TXMD.US)$ shares are falling over 14% after the FDA rejected a request from the company.
$BlackRock 2022 Global Income Opportunity(BGIO.US)$ stock is dropping more than 9% as shares prepare to stop trading at the end of the year.
$Context Therapeutics(CNTX.US)$ shares are decreasing over 7% on no apparent news today.
$Vasta Platform(VSTA.US)$ stock is dipping more than 7% after rallying higher on Friday.
$X-Links™ Monthly Pay 2xLeveraged Mortgage REIT ETN(REML.US)$ stock is losing more than 5% of its value this morning.
$Energy Focus(EFOI.US)$ shares close out our pre-market stock movers down over 5% after a strong rally last week on new product launches.
$金髮舌頭實驗室(BDR.US)$在上週收到退市通知後，該公司股價暴跌25%。
$Avenue Treeutics(ATXI.US)$在為承銷的200萬美元股票發行定價後，股價下跌了21%以上。
$iShares US ETF信託商品精選策略(COMT.US)$在今天的盤前交易中，股票下跌了15%以上。
$TreateuticsMD(TXMD.US)$在FDA拒絕了該公司的請求後，該公司股價下跌了14%以上。
$貝萊德2022年全球收入機會(BGIO.US)$隨著股票準備在年底停止交易，股票下跌了超過9%。
$Context Treeutics(CNTX.US)$由於今天沒有明顯的消息，股價下跌了7%以上。
$VASTA平臺(VSTA.US)$在上週五反彈後，該股下跌逾7%。
$X-Links™月薪2x槓桿抵押房地產投資信託基金(REML.US)$今天上午，股票市值下跌了5%以上。
$Energy Focus(EFOI.US)$在上週新產品發佈強勁反彈後，股價收盤前下跌超過5%。